Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3

2020/09/07 by Ling Zou, Pär Matsson, Adrian Stecuła +5 · 11 citations
Chemistry · Medicine · #Biochemistry #Biology #Chemistry #Drug #Drug Transport and Resistance Mechanisms #Drug metabolism #HIV/AIDS drug development and treatment #Metabolite #Organic anion transporter 1 #Pharmacological Effects and Toxicity Studies #Pharmacology #Transporter

paper · doi:10.1016/j.xphs.2020.09.004

openalex publication_date 2020/09/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• Emerging Roles of the Human Solute Carrier 22 Family
• Drugs in COVID-19 Clinical Trials: Predicting Transporter-Mediated Drug-Drug Interactions Using In Vitro Assays and Real-World Data. [europepmc]
• Evaluation for Potential Drug-Drug Interaction of MT921 Using In Vitro Studies and Physiologically-Based Pharmacokinetic Models. [europepmc]
• Emerging Roles of the Human Solute Carrier 22 Family . [europepmc]
• The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. [europepmc]
• The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction. [europepmc]
• Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3. [europepmc]
• Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes. [europepmc]
• Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat. [europepmc]
• The SLC-ome of membrane transport: From molecular discovery to physiology and clinical applications. [europepmc]
• Role of metabolites in drug-drug interactions. [europepmc]